Bristol Myers Squibb (BMY) Change in Inventory (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Change in Inventory data on file, last reported at -$14.0 million in Q1 2026.

• Quarterly Change in Inventory fell 108.28% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 99.77% YoY) and the FY2025 annual result came in at $184.0 million, down 62.14% from the prior year.
• Change in Inventory grew to -$14.0 million in Q1 2026 per BMY's latest filing, from -$71.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $282.0 million in Q1 2023 and bottomed at -$175.0 million in Q4 2024.
• The 5-year median for Change in Inventory is $41.0 million (2022), against an average of $86.8 million.
• The widest annual swing landed in 2023, when Change in Inventory surged 28300.0%; it then tumbled 188.83% in 2024.
• Tracing BMY's Change in Inventory over 5 years: stood at $41.0 million in 2022, then soared by 380.49% to $197.0 million in 2023, then slumped by 188.83% to -$175.0 million in 2024, then surged by 59.43% to -$71.0 million in 2025, then soared by 80.28% to -$14.0 million in 2026.
• Per Business Quant, the three latest BMY Change in Inventory figures stand at -$14.0 million (Q1 2026), -$71.0 million (Q4 2025), and $90.0 million (Q3 2025).

Peer Comparison